For migraine patients who cannot tolerate oral medications, which route of administration of metoclopramide may be beneficial?

For migraine patients who cannot tolerate oral medications, which route of administration of metoclopramide may be beneficial?

• A. IV
• B. Subcutaneous
• C. Oral
• D. Intranasal

Answer: (A)

When a migraine patient cannot take medications by mouth, delivering the drug in a way that guarantees quick, reliable absorption is key. Metoclopramide acts both as an antiemetic and a prokinetic agent, which helps relieve nausea and can ease gastric stasis often seen with migraines. Administering it intravenously bypasses the GI tract entirely, providing a rapid, consistent onset of action essential in acute situations and in patients who are vomiting or unable to swallow. This makes IV metoclopramide the most effective choice in this scenario, since other routes (oral, subcutaneous, intranasal) either depend on GI absorption or are slower and more variable, making them less reliable when oral intake isn’t possible.

When a migraine patient cannot take medications by mouth, delivering the drug in a way that guarantees quick, reliable absorption is key. Metoclopramide acts both as an antiemetic and a prokinetic agent, which helps relieve nausea and can ease gastric stasis often seen with migraines. Administering it intravenously bypasses the GI tract entirely, providing a rapid, consistent onset of action essential in acute situations and in patients who are vomiting or unable to swallow. This makes IV metoclopramide the most effective choice in this scenario, since other routes (oral, subcutaneous, intranasal) either depend on GI absorption or are slower and more variable, making them less reliable when oral intake isn’t possible.